|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
|
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Net revenue | $ 210,000us-gaap_SalesRevenueNet | $ 28,000us-gaap_SalesRevenueNet | $ 296,000us-gaap_SalesRevenueNet | $ 62,000us-gaap_SalesRevenueNet |
| Cost of sales | 193,000us-gaap_CostOfGoodsSold | 19,000us-gaap_CostOfGoodsSold | 272,000us-gaap_CostOfGoodsSold | 40,000us-gaap_CostOfGoodsSold |
| Gross profit | 17,000us-gaap_GrossProfit | 9,000us-gaap_GrossProfit | 24,000us-gaap_GrossProfit | 22,000us-gaap_GrossProfit |
| Operating expenses: | ||||
| Selling and administrative expenses | 474,000us-gaap_SellingGeneralAndAdministrativeExpense | 342,000us-gaap_SellingGeneralAndAdministrativeExpense | 949,000us-gaap_SellingGeneralAndAdministrativeExpense | 612,000us-gaap_SellingGeneralAndAdministrativeExpense |
| Amortization of prepaid advisory fees | 1,000flux_AmortizationOfPrepaidAdvisoryFees | 414,000flux_AmortizationOfPrepaidAdvisoryFees | 33,000flux_AmortizationOfPrepaidAdvisoryFees | 825,000flux_AmortizationOfPrepaidAdvisoryFees |
| Research and development | 141,000us-gaap_ResearchAndDevelopmentExpense | 123,000us-gaap_ResearchAndDevelopmentExpense | 262,000us-gaap_ResearchAndDevelopmentExpense | 230,000us-gaap_ResearchAndDevelopmentExpense |
| Total operating expenses | 616,000us-gaap_OperatingExpenses | 879,000us-gaap_OperatingExpenses | 1,244,000us-gaap_OperatingExpenses | 1,667,000us-gaap_OperatingExpenses |
| Operating loss | (599,000)us-gaap_OperatingIncomeLoss | (870,000)us-gaap_OperatingIncomeLoss | (1,220,000)us-gaap_OperatingIncomeLoss | (1,645,000)us-gaap_OperatingIncomeLoss |
| Other income (expense): | ||||
| Change in fair value of derivate liabilities | 0us-gaap_GainLossOnDerivativeInstrumentsNetPretax | 2,000us-gaap_GainLossOnDerivativeInstrumentsNetPretax | 438,000us-gaap_GainLossOnDerivativeInstrumentsNetPretax | 83,000us-gaap_GainLossOnDerivativeInstrumentsNetPretax |
| Interest expense, net | (23,000)us-gaap_InterestIncomeExpenseNet | (47,000)us-gaap_InterestIncomeExpenseNet | (23,000)us-gaap_InterestIncomeExpenseNet | (100,000)us-gaap_InterestIncomeExpenseNet |
| Other income (expense) | 4,000us-gaap_OtherNonoperatingIncomeExpense | 0us-gaap_OtherNonoperatingIncomeExpense | (10,000)us-gaap_OtherNonoperatingIncomeExpense | 0us-gaap_OtherNonoperatingIncomeExpense |
| Net loss | $ (618,000)us-gaap_NetIncomeLoss | $ (915,000)us-gaap_NetIncomeLoss | $ (815,000)us-gaap_NetIncomeLoss | $ (1,662,000)us-gaap_NetIncomeLoss |
| Net loss per share - basic and diluted | $ (0.01)us-gaap_EarningsPerShareBasic | $ (0.02)us-gaap_EarningsPerShareBasic | $ (0.01)us-gaap_EarningsPerShareBasic | $ (0.03)us-gaap_EarningsPerShareBasic |
| Weighted average number of common shares outstanding - basic and diluted | 97,399,546us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 47,715,793us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 95,628,315us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 47,604,706us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| X | ||||||||||
|
- Definition
The charge against earnings in the period representing the allocation of amortization of prepaid advisory fees. No definition available.
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net amount of operating interest income (expense). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|